Six Biotech Companies Developing Next-Generation Prostate Cancer Treatments
New biotech innovations are advancing prostate cancer therapy with promising approaches for better patient outcomes.
265 articles
New biotech innovations are advancing prostate cancer therapy with promising approaches for better patient outcomes.
Key biotech companies developing T cell engager therapies that redirect immune cells to fight cancer more effectively.
Australian biotech company creates targeted treatment that attacks malignant plasma cells while sparing healthy ones in multiple myeloma patients.
New p-tau217 blood test forecasts Alzheimer's symptoms within 3-4 years, potentially revolutionizing early intervention strategies.
Simple scans measuring brain blood flow and oxygen levels could detect Alzheimer's risk earlier than current methods by focusing on vascular health.
New research suggests shingles vaccination in adults 70+ is linked to slower biological aging and reduced inflammation markers.
Massive study of 270,000 people reveals higher tyrosine levels linked to reduced male lifespan, raising supplement safety questions.
American Heart Association projects dramatic surge in cardiovascular disease among women, driven by rising blood pressure, diabetes, and obesity.
Massive cellular atlas shows aging starts earlier than expected and happens in sync across 21 organs, opening doors to targeted therapies.
New research identifies LRG1 protein as early trigger of diabetic retinopathy, opening door to prevention-based treatments.
UK study of 165,000 dementia patients finds risperidone increases stroke risk across all groups, challenging safety assumptions.
New research reveals five ways microscopic plastic particles could damage brain health and accelerate neurodegenerative diseases.